217 related articles for article (PubMed ID: 32407638)
1. Bronchial Rheoplasty for Treatment of Chronic Bronchitis. Twelve-Month Results from a Multicenter Clinical Trial.
Valipour A; Fernandez-Bussy S; Ing AJ; Steinfort DP; Snell GI; Williamson JP; Saghaie T; Irving LB; Dabscheck EJ; Krimsky WS; Waldstreicher J
Am J Respir Crit Care Med; 2020 Sep; 202(5):681-689. PubMed ID: 32407638
[No Abstract] [Full Text] [Related]
2. Bronchial rheoplasty for chronic bronchitis: 2-year results from a US feasibility study with RheOx.
Sciurba FC; Dransfield MT; Kim V; Marchetti N; Comellas A; Hogarth DK; Majid A
BMJ Open Respir Res; 2023 Dec; 10(1):. PubMed ID: 38151258
[TBL] [Abstract][Full Text] [Related]
3. Clinical phenotypes of COPD and health-related quality of life: a cross-sectional study.
Chai CS; Liam CK; Pang YK; Ng DL; Tan SB; Wong TS; Sia JE
Int J Chron Obstruct Pulmon Dis; 2019; 14():565-573. PubMed ID: 30880946
[TBL] [Abstract][Full Text] [Related]
4. A prospective safety and feasibility study of metered cryospray for patients with chronic bronchitis in COPD.
Garner JL; Shaipanich T; Hartman JE; Orton CM; Caneja C; Klooster K; Thornton J; Sin DD; Slebos DJ; Shah PL
Eur Respir J; 2020 Dec; 56(6):. PubMed ID: 32586881
[TBL] [Abstract][Full Text] [Related]
5. Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD).
Ni H; Moe S; Soe Z; Myint KT; Viswanathan KN
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011594. PubMed ID: 30536566
[TBL] [Abstract][Full Text] [Related]
6. Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.
Fraser A; Poole P
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013343. PubMed ID: 36373977
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.
Janjua S; Mathioudakis AG; Fortescue R; Walker RA; Sharif S; Threapleton CJ; Dias S
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013198. PubMed ID: 33448349
[TBL] [Abstract][Full Text] [Related]
8. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
[TBL] [Abstract][Full Text] [Related]
9. Retreatment of symptomatic chronic bronchitis with bronchial rheoplasty.
Klemm T; Krimsky W; Welz K; Valipour A
BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38367996
[TBL] [Abstract][Full Text] [Related]
10. Safety and Adverse Events after Targeted Lung Denervation for Symptomatic Moderate to Severe Chronic Obstructive Pulmonary Disease (AIRFLOW). A Multicenter Randomized Controlled Clinical Trial.
Slebos DJ; Shah PL; Herth FJF; Pison C; Schumann C; Hübner RH; Bonta PI; Kessler R; Gesierich W; Darwiche K; Lamprecht B; Perez T; Skowasch D; Deslee G; Marceau A; Sciurba FC; Gosens R; Hartman JE; Srikanthan K; Duller M; Valipour A;
Am J Respir Crit Care Med; 2019 Dec; 200(12):1477-1486. PubMed ID: 31404499
[No Abstract] [Full Text] [Related]
11. [Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].
Ning P; Guo YF; Sun TY; Zhang HS; Chai D; Li XM
Zhonghua Nei Ke Za Zhi; 2016 Sep; 55(9):679-83. PubMed ID: 27586974
[TBL] [Abstract][Full Text] [Related]
12. Effect of SGRQ-Defined Chronic Bronchitis at Baseline on Treatment Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate.
Tashkin DP; Ozol-Godfrey A; Sharma S; Sanjar S
Int J Chron Obstruct Pulmon Dis; 2021; 16():945-955. PubMed ID: 33880019
[TBL] [Abstract][Full Text] [Related]
13. Alternative definitions of chronic bronchitis and their correlation with CT parameters.
Lim JU; Lee JH; Kim TH; Lee JS; Lee SD; Oh YM; Rhee CK
Int J Chron Obstruct Pulmon Dis; 2018; 13():1893-1899. PubMed ID: 29942122
[TBL] [Abstract][Full Text] [Related]
14. CAT Score and SGRQ Definitions of Chronic Bronchitis as an Alternative to the Classical Definition.
Choi JY; Yoon HK; Shin KC; Park SY; Lee CY; Ra SW; Jung KS; Yoo KH; Lee CH; Rhee CK
Int J Chron Obstruct Pulmon Dis; 2019; 14():3043-3052. PubMed ID: 31920301
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Herath SC; Normansell R; Maisey S; Poole P
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD009764. PubMed ID: 30376188
[TBL] [Abstract][Full Text] [Related]
16. Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD).
Horita N; Goto A; Shibata Y; Ota E; Nakashima K; Nagai K; Kaneko T
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD012066. PubMed ID: 28185242
[TBL] [Abstract][Full Text] [Related]
17. Chronic Bronchitis Is Associated With Worse Symptoms and Quality of Life Than Chronic Airflow Obstruction.
Meek PM; Petersen H; Washko GR; Diaz AA; Klm V; Sood A; Tesfaigzi Y
Chest; 2015 Aug; 148(2):408-416. PubMed ID: 25741880
[TBL] [Abstract][Full Text] [Related]
18. Three-Month Variability of Commonly Evaluated Biomarkers in Clinically Stable COPD.
Park SC; Saiphoklang N; Phillips J; Wilgus ML; Buhr RG; Tashkin DP; Cooper CB; Barjaktarevic I
Int J Chron Obstruct Pulmon Dis; 2023; 18():1475-1486. PubMed ID: 37485051
[TBL] [Abstract][Full Text] [Related]
19. Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease.
Maqsood U; Ho TN; Palmer K; Eccles FJ; Munavvar M; Wang R; Crossingham I; Evans DJ
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012930. PubMed ID: 30839102
[TBL] [Abstract][Full Text] [Related]
20. Long-acting beta2-agonists for chronic obstructive pulmonary disease.
Kew KM; Mavergames C; Walters JA
Cochrane Database Syst Rev; 2013 Oct; (10):CD010177. PubMed ID: 24127118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
